Anitha Murugan v. The Superintendent Of Police , Salem
IN THE HIGH COURT OF JUDICATURE AT MADRAS
DATED : 18.11.2022
CORAM:
THE HON'BLE Ms.JUSTICE R.N.MANJULA Anitha Murugan ... Petitioner Vs.
1.The Superintendent of Police, Salem District, Salem.
2.The Inspector of Police, D3, Suramangalam Police Station, Salem.
... Respondents PRAYER : Criminal Original Petition is filed under Section 482 of Cr.P.C., to direct the respondent to register a case on the basis of the petitioner's complaint dated 31.05.2022 and file an FIR.
For Petitioner : Mr.S.Gowrishankar For Respondents : Mr.S.Santhosh, Govt. Advocate (Crl.Side)
O R D E R
This Criminal Original Petition has been filed to direct the respondent to register a case on the basis of the petitioner's complaint dated 31.05.2022. 1/4
2. Heard the learned counsel for the petitioner and the learned Government Advocate (Crl.Side) appearing for the respondents.
3. The learned counsel for the petitioner submitted that she has given a complaint on 31.05.2022, against one S.B.Parthiban to the Commissioner of Police, Salem and the same was forwarded to the Superintendent of Police, Salem for taking action; but, so far no fruitful action has been taken.
4. The learned Government Advocate (Crl.Side) submitted that current paper enquiry has been initiated in CSR No.1036 of 2022 by the second respondent police to whom the first respondent has sent the complaint for enquiry and for appropriate action.
5. Since the petitioner has given a complaint as early as in the month of May 2022, it is appropriate to direct the second respondent to complete the enquiry and do the needful in accordance with law within a period of four weeks from the date of receipt of a copy of this order. 2/4
6. With the above observations, this Criminal Original Petition is disposed.
Index: Yes/No 18.11.2022 Speaking / Non Speaking Order gsk To 1.The Superintendent of Police, Salem District, Salem.
2.The Inspector of Police, D3, Suramangalam Police Station, Salem.
3.The Public Prosecutor, High Court, Madras.
3/4
R.N.MANJULA, J.
gsk 18.11.2022 4/4